Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop
growing or die. Biological therapies such as gefitinib may interfere with the growth of the
tumor cells and slow the growth of the tumor. Combining chemotherapy with gefitinib may kill
more tumor cells. Phase II trial to study the effectiveness of combining chemotherapy with
gefitinib in treating patients who have metastatic transitional cell cancer of the urothelium